Abstract
Background To investigate the work status, neurological recovery, and quality of life of cardiac arrest survivors within 1 year after hospital discharge.
Methods A retrospective single center study included 71 non-traumatic adult cardiac arrest patients between 2017 and 2020, who survived more than 1 year after hospital discharge and agreed to participate the study. Questionnaire interviews through telephone visits were conducted with the enrolled patients, assessing their work status, neurological recovery, and quality of life at 3 months and 1 year after hospital discharge. Additionally, their use of medical services was also collected.
Results Of the enrolled patients, 67 (94.4%) had a cerebral performance category (CPC) of 1 at discharge and the majority of patients (90.1%) returned home. Sixty-seven patients (94.4%) returned for outpatient visits at a median time of 6 days, 23 patients (32.4%) visited the ER at a median time of 74 days, and 22 patients (31.0%) were readmitted to the hospital at a median time of 58 days. In terms of mobility, self-care, usual activities, pain/discomfort, and health state assessed using the EQ-5D-5L, a significant decrease in impairment was observed from 3 months to 1 year. Moreover, patients demonstrated improved work status as well as improved scores for overall quality of life, general health, physical, psychological, social relations, and environmental status evaluated using the WHOQOL-BREF.
Conclusions Within 1 year following hospital discharge, a considerable number of cardiac arrest survivors require medical support. However, a continual improvement in work status and quality of life were observed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No special.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Institutional Review Board of NTUH (202107138RIND).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.